EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1T3: Syndax Pharmaceuticals Inc

08 Apr 2026
LAST:

21.66

CHANGE:
 0.73		OPEN:
21.66		HIGH:
21.66		ASK:
0.00		VOLUME:
0
CHG(%):
3.49		PREV:
20.93		LOW:
21.66		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Apr 2621.6621.6621.6621.660
07 Apr 2620.7820.9320.7820.9390
02 Apr 2620.2020.2020.2020.200
01 Apr 2620.0020.0020.0020.000
31 Mar 2619.6019.6019.6019.600
30 Mar 2620.2020.2020.2020.200
27 Mar 2621.2021.2021.2021.200
26 Mar 2620.6020.6020.6020.60400
25 Mar 2620.6020.6020.6020.60400
24 Mar 2620.4020.4020.4020.40400

PROFILE

Name:Syndax Pharmaceuticals Inc
About:Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:730 Third Avenue, New York, NY, United States, 10017
Website:https://syndax.com
ISIN:US87164F1057
LEI:529900OF94TRHKZVBS87

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-3.33 
Forward P/E:-5.19 
PEG Ratio:-5.19 
Price to Sales:9.68 
Price to Book:11.00 
Profit Margin:-2.80 
Operating Margin:-1.25 
Return on Assets:-0.39 
Return on Equity:-1.29 
Revenue:94.55M 
Shares:86.14M 
Market Cap:1.866B 

TECHNICAL INDICATORS

MA5:20.485.8%
MA10:20.545.5%
MA20:20.545.5%
MA50:18.4117.6%
MA100:15.7537.5%
MA200:12.5372.8%
STO9:100.00 
STO14:100.00 
RSI14:60.47 
MTM14:1.26
ROC14:0.06 
ATR:0.36 
Week High:21.660.0%
Week Low:20.008.3%
Month High:21.660.0%
Month Low:18.5072.8%
Year High:21.660.0%
Year Low:7.18201.5%
Volatility:16.85